These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 11063612)

  • 1. Sulfoxide-containing aromatic nitrogen mustards as hypoxia-directed bioreductive cytotoxins.
    Sun ZY; Botros E; Su AD; Kim Y; Wang E; Baturay NZ; Kwon CH
    J Med Chem; 2000 Nov; 43(22):4160-8. PubMed ID: 11063612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p-(Methylsulfinyl)phenyl nitrogen mustard as a novel bioreductive prodrug selective against hypoxic tumors.
    Kwon CH; Blanco DR; Baturay N
    J Med Chem; 1992 May; 35(11):2137-9. PubMed ID: 1597864
    [No Abstract]   [Full Text] [Related]  

  • 3. Hypoxia-selective antitumor agents. 12. Nitrobenzyl quaternary salts as bioreductive prodrugs of the alkylating agent mechlorethamine.
    Tercel M; Wilson WR; Anderson RF; Denny WA
    J Med Chem; 1996 Mar; 39(5):1084-94. PubMed ID: 8676343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel design strategy for stable metal complexes of nitrogen mustards as bioreductive prodrugs.
    Parker LL; Lacy SM; Farrugia LJ; Evans C; Robins DJ; O'Hare CC; Hartley JA; Jaffar M; Stratford IJ
    J Med Chem; 2004 Nov; 47(23):5683-9. PubMed ID: 15509167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitroimidazole-based "extruded mustards' designed as reductively activated hypoxia-selective cytotoxins.
    Hay MP; Denny WA; Wilson WR
    Anticancer Drug Des; 1996 Jul; 11(5):383-402. PubMed ID: 8765531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-immolative nitrogen mustard prodrugs for suicide gene therapy.
    Niculescu-Duvaz D; Niculescu-Duvaz I; Friedlos F; Martin J; Spooner R; Davies L; Marais R; Springer CJ
    J Med Chem; 1998 Dec; 41(26):5297-309. PubMed ID: 9857097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1,2-benzisoxazole phosphorodiamidates as novel anticancer prodrugs requiring bioreductive activation.
    Jain M; Kwon CH
    J Med Chem; 2003 Dec; 46(25):5428-36. PubMed ID: 14640551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia-selective antitumor agents. 16. Nitroarylmethyl quaternary salts as bioreductive prodrugs of the alkylating agent mechlorethamine.
    Tercel M; Lee AE; Hogg A; Anderson RF; Lee HH; Siim BG; Denny WA; Wilson WR
    J Med Chem; 2001 Oct; 44(21):3511-22. PubMed ID: 11585455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Racemic and chiral sulfoxides as potential prodrugs of 4-pyrone COX-2 inhibitors.
    Caturla F; Amat M; Reinoso RF; Calaf E; Warrellow G
    Bioorg Med Chem Lett; 2006 Jul; 16(13):3605-8. PubMed ID: 16647258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and synthesis of brefeldin A sulfide derivatives as prodrug candidates with enhanced aqueous solubilities.
    Argade AB; Devraj R; Vroman JA; Haugwitz RD; Hollingshead M; Cushman M
    J Med Chem; 1998 Aug; 41(18):3337-46. PubMed ID: 9719586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia-selective antitumor agents. 7. Metal complexes of aliphatic mustards as a new class of hypoxia-selective cytotoxins. Synthesis and evaluation of cobalt(III) complexes of bidentate mustards.
    Ware DC; Palmer BD; Wilson WR; Denny WA
    J Med Chem; 1993 Jun; 36(13):1839-46. PubMed ID: 8515422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and evaluation of nitroheterocyclic carbamate prodrugs for use with nitroreductase-mediated gene-directed enzyme prodrug therapy.
    Hay MP; Anderson RF; Ferry DM; Wilson WR; Denny WA
    J Med Chem; 2003 Dec; 46(25):5533-45. PubMed ID: 14640560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and structure-activity relationships for 2,4-dinitrobenzamide-5-mustards as prodrugs for the Escherichia coli nfsB nitroreductase in gene therapy.
    Atwell GJ; Yang S; Pruijn FB; Pullen SM; Hogg A; Patterson AV; Wilson WR; Denny WA
    J Med Chem; 2007 Mar; 50(6):1197-212. PubMed ID: 17326614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and anti-cancer activity of 2,6-disubstituted N-methylpiperidine derivatives and their N-oxides.
    Henderson ND; Plumb JA; Robins DJ; Workman P
    Anticancer Drug Des; 1996 Sep; 11(6):421-38. PubMed ID: 8836108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muscarinic antagonists with multiple stereocenters: Synthesis, affinity profile and functional activity of isomeric 1-methyl-2-(2,2-alkylaryl-1,3-oxathiolan-5-yl)pyrrolidine sulfoxide derivatives.
    Dei S; Bellucci C; Buccioni M; Ferraroni M; Guandalini L; Manetti D; Marucci G; Matucci R; Nesi M; Romanelli MN; Scapecchi S; Teodori E
    Bioorg Med Chem; 2008 May; 16(10):5490-500. PubMed ID: 18455407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of sulfonate leaving groups on the hypoxia-selective toxicity of nitro analogs of the duocarmycins.
    Ashoorzadeh A; Atwell GJ; Pruijn FB; Wilson WR; Tercel M; Denny WA; Stevenson RJ
    Bioorg Med Chem; 2011 Aug; 19(16):4851-60. PubMed ID: 21767954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biological evaluation of nitrogen mustard derivatives of purine bases.
    Boëns B; Azouz M; Ouk TS; Zerrouki R
    Nucleosides Nucleotides Nucleic Acids; 2013; 32(2):69-80. PubMed ID: 23448142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and evaluation of stable bidentate transition metal complexes of 1-(chloromethyl)-5-hydroxy-3-(5,6,7-trimethoxyindol-2-ylcarbonyl)-2,3-dihydro-1H-pyrrolo[3,2-f]quinoline (seco-6-azaCBI-TMI) as hypoxia selective cytotoxins.
    Milbank JB; Stevenson RJ; Ware DC; Chang JY; Tercel M; Ahn GO; Wilson WR; Denny WA
    J Med Chem; 2009 Nov; 52(21):6822-34. PubMed ID: 19821576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of alkylating agent prodrugs derived from phenol and aniline mustards: a new clinical candidate prodrug (ZD2767) for antibody-directed enzyme prodrug therapy (ADEPT).
    Springer CJ; Dowell R; Burke PJ; Hadley E; Davis DH; Blakey DC; Melton RG; Niculescu-Duvaz I
    J Med Chem; 1995 Dec; 38(26):5051-65. PubMed ID: 8544182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity relationships for 4-nitrobenzyl carbamates of 5-aminobenz[e]indoline minor groove alkylating agents as prodrugs for GDEPT in conjunction with E. coli nitroreductase.
    Hay MP; Atwell GJ; Wilson WR; Pullen SM; Denny WA
    J Med Chem; 2003 Jun; 46(12):2456-66. PubMed ID: 12773049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.